NFE2L2 and breast carcinoma: UA may act as cytotoxic agent via Nrf2 pathway inhibition; Zhang et al. have reported that UA suppressed the Nrf2- mediated cell proliferation regulated by EGFR and Keap1 in MDA-MB-231 breast cancer cells in a dose-dependent manner.